Nifty Pharma

Nifty Pharma Index captures the performance of the pharmaceutical sector and comprises 20 companies listed on the National Stock Exchange of India (NSE). It is commonly used as a benchmark to track overall market performance and economic trends.

The current value of Nifty Pharma is 26,311.55.

The 1 year return of Nifty Pharma is 21.06%.

The 3 year return of Nifty Pharma is 70.60%.

The 5 year return of Nifty Pharma is 80.37%.

The 10 year return of Nifty Pharma is 126.08%.

Over the past 52 weeks, Nifty Pharma has traded between a low of ₹21,149.90 and a high of ₹27,255.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

The Nifty Pharma index represents the collective performance of its constituent companies. It reflects market sentiment and price movements within the segment or sector the index is designed to track.

The Nifty Pharma index is calculated using a Periodic Capped Free Float methodology, where constituent companies are weighted based on their market value and free-float shares available for public trading.

The Nifty Pharma index consists of 20 companies selected based on predefined eligibility criteria. The composition of the index may change over time due to periodic reviews and rebalancing.

The current value of the Nifty Pharma index is 26,311.55. Index values fluctuate throughout the trading session based on price movements of the underlying constituent stocks.

The historical performance of the Nifty Pharma index can be reviewed using the performance charts and data available on this page. Historical returns help in understanding long-term trends and volatility.

The Nifty Pharma index is rebalanced Semi-Annually. Rebalancing ensures that the index continues to reflect its stated objective and remains aligned with market conditions.

Movements in the Nifty Pharma index are influenced by price changes in constituent stocks, corporate earnings, macroeconomic indicators, interest rates, global market trends, and overall investor sentiment.